Clean Vision Corporation CLNV

Q3 FY2025 · ended Sep 30, 2025 · Revenue $62,064, +78.3% YoY · Filed Nov 19, 2025

Clean Vision Corporation (CLNV) files with the SEC under industry code 2860, Industrial Organic Chemicals. In Q3 of fiscal 2025, the quarter ended Sep 30, 2025, it reported revenue of $62,064 and a net loss of $1.8 million. As of Sep 30, 2025 it held $575,678 in cash and investments and $3.4 million in total debt.

Revenue
$62,064
+78.3% vs year-ago quarter
Net income
$-1.83M
-17.6% vs year-ago quarter
Operating cash flow
$-9.60M
-7407.5% vs year-ago quarter
Free cash flow
—
EPS
$0.00
Dividend per share
None
Shares outstanding
1.15B
+42.7% vs year-ago quarter
Net cash
$-2.87M
Q3 FY2025
Operating margin
-3321.9%
TTM

Company profile

Industry
Industrial Organic Chemicals (SIC 2860)
Listed as
CLNV (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Manhattan Beach, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1391426
Former names
Byzen Digital, Inc. (until Apr 7, 2021); CHINA VITUP HEALTH CARE HOLDINGS, INC. (until Mar 30, 2012)

Other Industrial Organic Chemicals companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Q3 FY2024
Sep 30, 2024
Revenue
$62,064
$52,612
$10,525
$123,094
$34,799
Operating income
-$1.2M
-$1.9M
-$1.0M
-$4.1M
-$925,203
Net income
-$1.8M
-$417,359
-$3.2M
-$8.5M
-$1.6M
Diluted EPS
$0.00
$0.00
$0.00
-$0.01
$0.00
Operating cash flow
-$9.6M
$6.8M
-$2.9M
-$3.4M
-$127,887
Total assets
$20.8M
$21.7M
$17.7M
$13.1M
$10.3M
Total liabilities
$36.3M
$36.0M
$32.6M
$25.0M
$15.9M
Stockholders' equity
-$15.8M
-$14.3M
-$14.9M
-$11.9M
-$5.6M
Cash and investments
$575,678
$2.8M
$1.2M
$885,835
$4,180
Total debt
$3.4M
$3.5M
$3.6M
$1.8M
$1.8M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 19, 2025 Sep 30, 2025
10-Q Quarterly report Aug 19, 2025 Jun 30, 2025
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
Jul 29, 2025 May 13, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-K Annual report Apr 15, 2025 Dec 31, 2024
10-Q Quarterly report Nov 19, 2024 Sep 30, 2024

Source: SEC EDGAR filings. This is company-reported data, not investment advice.